MarketCap
Facebook
X
Telegram
Immunome Shares | IMNM
Annual Shares Immunome
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.4 M | 58.6 M | 19.8 M | 12.1 M | 11.5 M | 10 M | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 87.4 M | 10 M | 33.3 M |
Quarterly Shares Immunome
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87 M | 113 M | - | 88 M | 87 M | 79.4 M | 64.5 M | 60.2 M | 59.9 M | 51.5 M | 43.3 M | 12.2 M | 12.2 M | 12.2 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 11.9 M | 11.5 M | 10.6 M | 10.6 M | 1.11 M | 1.1 M | 1.1 M | 1.1 M | 1.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 113 M | 1.09 M | 32.6 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aphria Inc.
APHA
|
258 M | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
42.1 M | - | -0.90 % | $ 104 M |  USA |
 |
Chiasma, Inc.
CHMA
|
52.2 M | - | -6.00 % | $ 238 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
169 M | $ 3.37 | 4.66 % | $ 568 M |  Singapore |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
27.7 M | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
213 M | - | 0.38 % | $ 12.9 M |  Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
28 M | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
73 M | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
47.5 M | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
2.91 M | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
74.5 M | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
31 M | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
31.4 M | - | - | $ 6.81 B |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
169 M | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
3.1 M | - | - | $ 256 M | Canada |
 |
argenx SE
ARGX
|
61.3 M | $ 928.5 | 3.77 % | $ 56.9 B |  Niderland |
 |
XBiotech
XBIT
|
30.5 M | $ 1.88 | 0.53 % | $ 57.3 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
49.7 M | - | -2.54 % | $ 57.2 M | USA |
 |
Xencor
XNCR
|
74.2 M | $ 36.19 | 6.28 % | $ 2.69 B | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
32.8 M | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
20 M | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
62.8 M | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
23.3 M | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
1.7 M | $ 1.87 | 0.31 % | $ 3.18 M | USA |
 |
Translate Bio, Inc.
TBIO
|
51.4 M | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
83.8 M | - | - | $ 1.94 B | Canada |
 |
Exicure
XCUR
|
6.3 M | $ 0.91 | 2.77 % | $ 5.73 M | USA |
 |
Urovant Sciences Ltd.
UROV
|
30.4 B | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
56.8 M | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
43.2 M | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
53.7 M | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
1.84 M | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
213 M | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
79.3 M | $ 39.02 | 3.56 % | $ 3.09 B | Canada |
 |
Leap Therapeutics
LPTX
|
66.1 M | - | 368.57 % | $ 41.9 M | USA |
 |
Zymeworks
ZYME
|
51.6 M | $ 29.63 | 3.1 % | $ 1.53 B | Canada |
 |
Adial Pharmaceuticals
ADIL
|
669 K | $ 3.15 | -35.42 % | $ 2.11 M | USA |
 |
ADMA Biologics
ADMA
|
238 M | $ 12.73 | -3.67 % | $ 3.03 B | USA |
 |
Cortexyme
CRTX
|
50.1 M | - | -1.05 % | $ 67.1 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 3.6 | -9.22 % | $ 789 M | Britain |
 |
Daré Bioscience
DARE
|
11.2 M | $ 0.64 | 2.96 % | $ 7.15 M | USA |
 |
Fate Therapeutics
FATE
|
119 M | $ 1.84 | -0.54 % | $ 219 M | USA |
 |
Greenwich LifeSciences
GLSI
|
13.5 M | $ 15.15 | 3.41 % | $ 205 M | USA |
 |
Halozyme Therapeutics
HALO
|
120 M | $ 103.85 | -15.54 % | $ 12.4 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
858 M | $ 15.16 | 6.76 % | $ 13 B | China |
 |
Aptorum Group Limited
APM
|
7.35 M | - | - | $ 5.72 M | China |
 |
iBio
IBIO
|
104 M | $ 0.74 | 0.77 % | $ 77 M | USA |
 |
Kodiak Sciences
KOD
|
53.2 M | $ 99.33 | 9.13 % | $ 5.29 B | USA |
 |
Karyopharm Therapeutics
KPTI
|
10.9 K | $ 0.05 | -14.81 % | $ 547 | USA |
 |
FSD Pharma
HUGE
|
38.7 M | - | 5743.5 % | $ 69.7 M | Canada |